Edmonton, Canada

Lei Ling

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: C V Technologies Inc., Fx Life Sciences International Gmbh, Afexa Life Sciences Inc.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Ling. Retrieved from https://idiyas.com/inventor/lei-ling-zx7f23mv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0


Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Lei Ling from Edmonton, CA

Introduction

Lei Ling, a prolific inventor based in Edmonton, Canada, holds an impressive portfolio of eight patents. His expertise lies in creating synergistic pharmaceutical compositions aimed at enhancing both human and veterinary health. Through his innovative approaches, Lei has made significant strides in the field of pharmaceuticals, particularly concerning cardiovascular diseases and immune system enhancement.

Latest Patents

Among Lei Ling's latest patents is the "Synergistic pharmaceutical composition, method of making same and use of same," which details a medicinal combination of herbs, herbal extracts, and their chemical constituents. This invention focuses on a blood lipid level lowering composition that includes Ku ding cha and berberine, alongside optional active ingredients. The methods outlined in this patent not only describe the extraction processes but also the synergistic amounts required for effective use in treating or reducing the risks associated with various diseases, especially cardiovascular conditions.

Another notable patent is titled "Processes of making North American ginseng fractions, products containing them, and use as immunomodulators." This patent encompasses the chemical processes necessary for preparing fractions from North American ginseng, revealing pharmaceutical compositions that can enhance cytokine and antibody production. It aims to provide therapeutic solutions for conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS, and cancer.

Career Highlights

Throughout his career, Lei Ling has collaborated with reputable companies, including C V Technologies Inc. and Fx Life Sciences International GmbH. His innovative work has not only contributed to the companies he worked with but has also advanced the field of pharmaceutical research and development.

Collaborations

Lei has worked alongside notable individuals like Jacqueline J Shan and Peter K T Pang. These collaborations have facilitated a dynamic exchange of ideas and expertise, enriching the development of his innovative pharmaceutical compositions.

Conclusion

In summary, Lei Ling's impactful patent contributions reflect his dedication to advancing healthcare solutions through innovative pharmaceutical compositions. His work continues to offer promising developments in treating critical health conditions and enhancing overall well-being. As he forges ahead, the potential for his inventions to change lives remains significant.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…